Filing Details

Accession Number:
0001415889-24-006070
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-01 16:05:24
Reporting Period:
2024-02-28
Accepted Time:
2024-03-01 16:05:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1109354 Bruker Corp BRKR Laboratory Analytical Instruments (3826) 043110160
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1739999 Falko Busse 40 Manning Road
Billerica MA 01821
President, Biospin Group No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-28 12,000 $19.82 44,859 No 4 M Direct
Common Stock Acquisiton 2024-02-28 7,097 $22.19 51,956 No 4 M Direct
Common Stock Acquisiton 2024-02-28 4,384 $34.02 56,340 No 4 M Direct
Common Stock Acquisiton 2024-02-28 4,641 $41.95 60,981 No 4 M Direct
Common Stock Disposition 2024-02-28 13,852 $86.06 47,129 No 4 S Direct
Common Stock Disposition 2024-02-28 12,770 $84.97 34,359 No 4 S Direct
Common Stock Disposition 2024-02-28 1,500 $84.48 32,859 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Purchase) Disposition 2024-02-28 12,000 $0.00 12,000 $19.82
Common Stock Stock Option (Right to Purchase) Disposition 2024-02-28 7,097 $0.00 7,097 $22.19
Common Stock Stock Option (Right to Purchase) Disposition 2024-02-28 4,384 $0.00 4,384 $34.02
Common Stock Stock Option (Right to Purchase) Disposition 2024-02-28 4,641 $0.00 4,641 $41.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-08-07 No 4 M Direct
0 2026-10-04 No 4 M Direct
0 2028-08-09 No 4 M Direct
0 2029-08-08 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.52 to $86.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.52 to $85.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.46 to $84.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
  5. The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
  6. The stock option granted to the Reporting Person on August 9, 2018 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
  7. The stock option granted to the Reporting Person on August 8, 2019 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.